| (2S,3R,4S)-CCG |
(2S,1'R,2'S)-2-(2-羧基环丙基)甘氨酸 |
117857-95-1 |
| (2R,4S,5R)-4-(hydroxymethyl)-2-phenyl-1,3-dioxan-5-ol |
1,3-O-亚苄基-L-赤藓糖醇 |
117122-84-6 |
| [3-(2-Chloro-pyrimidin-4-yl)-phenyl]-methanol |
3-(2-氯-4-吡啶基)苯甲醇 |
859517-90-1 |
| 6-IODONORDIHYDROCAPSAICIN |
葡聚糖凝胶 |
859171-97-4 |
| CEP-11981 |
1.11-(2-METHYLPROPYL)-12,13-DIHYDRO-2-METHYL-8-(PYRIMIDIN-2-YLAMINO)-4H-INDAZOLO(5,4-A)PYRROLO(3,4-C)CARBAZOL-4-ONE |
856691-93-5 |
| 6-oxaspiro [4.5] decan-9-one |
6-氧杂螺[4.5]癸烷-9-酮 |
855398-57-1 |
| 6-Oxaspiro[4.5]decan-9-ol |
6-氧杂螺[4.5]癸烷-9-醇 |
855398-58-2 |
| Methyl (s)-2-aMino-3-(3-(Methylsulfonyl)phenyl)propanoate |
S-2-氨基-3-甲砜基-苯丙氨酸甲酯 |
851785-28-9 |
| PDK1 Inhibitor |
PDK1 INHIBITOR |
850717-64-5 |
| 1-(3-METHYLBUTYL)-1H-PYRAZOLE-4-BORONIC ACID |
1-(3-甲基丁基)-1H-吡唑-4-硼酸 |
847818-58-0 |
| filgotinib |
FILGOTINIB |
848416-07-9 |
| 2-METHYL-5-HYDROXYTRYPTAMINE HYDROCHLORIDE |
2-METHYL-5-HT HYDROCHLORIDE |
845861-49-6 |
| Mitoquinone mesylate |
米托蒽醌甲磺酸盐 |
845959-50-4 |
| Boronic Acid, [1-(Triphenylmethyl)-1H-Pyrazol-4-YL |
硼酸,[1-(三苯甲基)-1H-吡唑-4-基 |
207307-51-5 |
| ISO-PPADS TETRASODIUM SALT |
PYRIDOXALPHOSPHATE-6-AZOPHENYL-2',5'-DISULFONIC ACID TETRASODIUM SALT |
207572-67-6 |
| tert-butyl 4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidine-1-carboxylate |
1015-A5 |
206989-63-1 |
| tert-butyl 4-(1,8-naphthyridin-2-yl)piperidine-1-carboxylate |
tert-butyl 4-(1,8-naphthyridin-2-yl)piperidine-1-carboxylate |
206989-62-0 |
| Liraglutide |
利拉鲁肽 |
204656-20-2 |
| (S)-A-METHYL-A-[[[(4-NITROPHENYL)AMINO]CARBONYL]AMINO]-N-[[1-(2-PYRIDINYL)CYCLOHEXYL]METHYL]-1H-INDOLE-3-PROPANAMIDE |
(2S)-3-(1H-INDOL-3-YL)-2-METHYL-2-[(4-NITROPHENYL)CARBAMOYLAMINO]-N-[(1-PYRIDIN-2-YLCYCLOHEXYL)METHYL]PROPANAMIDE |
204066-82-0 |
| PRASUGREL METABOLITE R-138727 |
普拉格雷活性代谢物 |
204204-73-9 |
